tiprankstipranks
Can-Fite BioPharma (CANF)
NYSE MKT:CANF
Holding CANF?
Track your performance easily

Can-Fite BioPharma (CANF) Technical Analysis

514 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
3Neutral
13Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
Can-Fite BioPharma’s (CANF) Moving Averages Convergence Divergence (MACD) indicator is -0.10, suggesting Can-Fite BioPharma is a Buy.
Can-Fite BioPharma’s (CANF) 20-Day exponential moving average is 2.15, while Can-Fite BioPharma’s (CANF) share price is $1.97, making it a Sell.
Can-Fite BioPharma’s (CANF) 50-Day exponential moving average is 2.27, while Can-Fite BioPharma’s (CANF) share price is $1.97, making it a Sell.

Can-Fite BioPharma (CANF) Pivot Points

Nov 22, 2024, 02:54 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.81
1.88
1.96
2.03
2.11
2.18
2.26
Fibonacci
1.88
1.94
1.98
2.03
2.09
2.13
2.18
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Can-Fite BioPharma (CANF) Moving Averages

Nov 22, 2024, 02:54 AM
Period
Simple
Exponential
MA5
2.00Buy
2.02Sell
MA10
2.04Sell
2.06Sell
MA20
2.16Sell
2.15Sell
MA50
2.24Sell
2.27Sell
MA100
2.53Sell
2.36Sell
MA200
2.41Sell
2.32Sell
Can-Fite BioPharma’s (CANF) 10-Day exponential moving average is 2.06, while Can-Fite BioPharma’s (CANF) share price is $1.97, making it a Sell.
Can-Fite BioPharma’s (CANF) 100-Day exponential moving average is 2.36, while Can-Fite BioPharma’s (CANF) share price is $1.97, making it a Sell.
Can-Fite BioPharma’s (CANF) stock price is $1.97 and Can-Fite BioPharma’s (CANF) 50-day simple moving average is 2.24, creating a Sell signal.
Can-Fite BioPharma’s (CANF) stock price is $1.97 and Can-Fite BioPharma’s (CANF) 100-day simple moving average is 2.53, creating a Sell signal.
Can-Fite BioPharma’s (CANF) stock price is $1.97 and Can-Fite BioPharma’s (CANF) 200-day simple moving average is 2.41, creating a Sell signal.

Can-Fite BioPharma (CANF) Technical Indicators

Nov 22, 2024, 02:54 AM
Name
Value
Implied Action
RSI (14)
38.19
Neutral
STOCH (9,6)
24.18
Neutral
STOCHRSI (14)
16.05
Buy
MACD (12,26)
-0.10
Buy
ADX (14)
14.40
Buy
Williams %R
-81.67
Buy
CCI (14)
-101.24
Buy
ATR (14)
0.20
-
Ultimate Oscillator
32.66
Neutral
ROC
-6.51
Sell
Can-Fite BioPharma’s (CANF) Relative Strength Index (RSI) is 38.19, creating a Neutral signal.
Can-Fite BioPharma’s (CANF) Trend Strength Indicator (ADX) is 14.40, creating a Buy signal.
Can-Fite BioPharma’s (CANF) Commodity Channel Index (CCI) is -101.24, creating a Buy signal.
Can-Fite BioPharma’s (CANF) Price Rate of Change (ROC) is -6.51, creating a Sell signal.

FAQ

Is CANF a Buy, Hold, or Sell?
Based on CANF’s technical indicators, CANF is a Sell.
    What is CANF’s RSI (14)?
    CANF’s RSI (14) is 38.19, which suggests CANF is a Neutral.
      What is CANF’s MACD?
      CANF’s MACD is -0.10, which suggests CANF is a Buy.
        What is CANF’s 5-day moving average?
        CANF’s 5-day moving average is 2.00, which suggests CANF is a Buy.
          What is CANF’s 20-day moving average?
          CANF 20-day moving average is 2.16, which suggests CANF is a Sell.
            What is CANF’s 50-day moving average?
            CANF’s 50-day moving average is 2.24, which suggests CANF is a Sell.
              What is CANF’s 200-day moving average?
              CANF’s 200-day moving average is 2.41, which suggests CANF is a Sell.
                What is CANF’s Williams % R (14)?
                CANF’s Williams % R (14) is -81.67, which suggests CANF is a Buy.
                  What is CANF’s CCI (14)?
                  CANF’s CCI (14) is -101.24, which suggests CANF is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis